Clinical Trials Directory

Trials / Completed

CompletedNCT05527756

Evaluation of the Cosmetic Outcomes of Totally Endoscopic Cardiac Surgery

Status
Completed
Phase
Study type
Observational
Enrollment
80 (actual)
Sponsor
Jessa Hospital · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Totally endoscopic cardiac surgery (TECS) is considered to have aesthetic advantages over conventional median sternotomy due to the smaller incisions. Most research regarding TECS focuses on clinical outcomes instead of cosmetic consequences. Following surgery, postoperative scarring is unavoidable and may negatively affect the patient's physical and emotional well-being. Therefore, this study aims to investigate the cosmesis after TECS.

Detailed description

Totally endoscopic cardiac surgery (TECS) is considered to have aesthetic advantages over conventional median sternotomy due to the smaller incisions. Most research regarding TECS focuses on clinical outcomes instead of cosmetic consequences. Following surgery, postoperative scarring is unavoidable and may negatively affect the patient's physical and emotional well-being. One previous study compared median sternotomy cardiac surgery and TECS in terms of the long-term cosmetic appearance of postoperative scars. They concluded that scars were considered more satisfactory, less painful, and itchy in the TECS group in the Chinese population. To our knowledge, this is the only study published regarding cosmetic consequences after TECS. Therefore, this study aims to investigate the cosmesis after TECS.

Conditions

Interventions

TypeNameDescription
OTHERScar Cosmesis Assessment and Rating (SCAR) scaleThe SCAR scale consists of two simple questions about symptoms (itch and pain) with yes/no response options that are responded to by the patient and six clinician-related items that are rated by observers through photos of the incisions. This scale includes both objective measurements and patient-reported symptoms
OTHERNumerical rating scale (NRS)The NRS scale, in which the patients score the cosmetic appearance of the scar from 0 to 10, is questioned.

Timeline

Start date
2022-10-21
Primary completion
2023-05-27
Completion
2023-05-27
First posted
2022-09-06
Last updated
2024-03-06

Locations

1 site across 1 country: Belgium

Source: ClinicalTrials.gov record NCT05527756. Inclusion in this directory is not an endorsement.